About Regenesis
Regenesis is a company based in Scottsdale (United States) founded in 1996.. Regenesis has raised $13.32 million across 4 funding rounds from investors including Solstice Capital, Fulcrum Equity Partners and TGap Ventures. Regenesis offers products and services including Reprieve, Provant, and Infinity. Regenesis operates in a competitive market with competitors including Organogenesis, Sofregen, Encellin, BioTissue and Reapplix, among others.
- Headquarter Scottsdale, United States
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$13.32 M (USD)
in 4 rounds
-
Latest Funding Round
$5.2 M (USD), Series C
Jun 10, 2011
-
Investors
Solstice Capital
& 4 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Regenesis
Regenesis offers a comprehensive portfolio of products and services, including Reprieve, Provant, and Infinity. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Electromagnetic therapy for non-drug home pain relief.
Home-based system for pain management support.
Advanced tool for electromagnetic pain relief.
Funding Insights of Regenesis
Regenesis has successfully raised a total of $13.32M across 4 strategic funding rounds. The most recent funding activity was a Series C round of $5.2 million completed in June 2011. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Series C — $5.2M
-
First Round
First Round
(22 Apr 2002)
- Investors Count 5
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2011 | Amount | Series C - Regenesis | Valuation | Fulcrum Equity Partners , TGap Ventures | |
| Jun, 2007 | Amount | Series B - Regenesis | Valuation |
investors |
|
| Jun, 2005 | Amount | Series B - Regenesis | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Regenesis
Regenesis has secured backing from 5 investors, including venture fund investors. Prominent investors backing the company include Solstice Capital, Fulcrum Equity Partners and TGap Ventures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity investments are managed across the United States.
|
Founded Year | Domain | Location | |
|
US focused seed & early stage Micro VC firm
|
Founded Year | Domain | Location | |
|
TGap Ventures is engaged in venture capital investments for startups.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Regenesis
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Regenesis
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Regenesis Comparisons
Competitors of Regenesis
Regenesis operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Organogenesis, Sofregen, Encellin, BioTissue and Reapplix, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Regenerative therapies for wound care are developed and commercialized.
|
|
| domain | founded_year | HQ Location |
Silk-derived biomaterials are developed for soft tissue repair in surgery.
|
|
| domain | founded_year | HQ Location |
Developer of regenerative materials
|
|
| domain | founded_year | HQ Location |
Regenerative biologic therapies for eye care are developed and provided.
|
|
| domain | founded_year | HQ Location |
Developer of patch system for wound healing
|
|
| domain | founded_year | HQ Location |
Synthetic electrospun scaffolds are provided for regenerative medical uses.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Regenesis
Frequently Asked Questions about Regenesis
When was Regenesis founded?
Regenesis was founded in 1996 and raised its 1st funding round 6 years after it was founded.
Where is Regenesis located?
Regenesis is headquartered in Scottsdale, United States. It is registered at Scottsdale, Arizona, United States.
Who is the current CEO of Regenesis?
Tom Eisiminger is the current CEO of Regenesis.
Is Regenesis a funded company?
Regenesis is a funded company, having raised a total of $13.32M across 4 funding rounds to date. The company's 1st funding round was a Series B of $2.13M, raised on Apr 22, 2002.
What does Regenesis do?
Regenesis was founded in 1996 in Scottsdale, United States, and operates in the medical devices sector focused on pain management. At-home solutions without drugs are delivered through electromagnetic shortwave diathermy therapy devices. Products offered include Reprieve 60, Reprieve Duo, and Reprieve, which support patient care in non-clinical settings across the United States.
Who are the top competitors of Regenesis?
Regenesis's top competitors include Organogenesis, GeniPhys and Acera Surgical.
What products or services does Regenesis offer?
Regenesis offers Reprieve, Provant, and Infinity.
Who are Regenesis's investors?
Regenesis has 5 investors. Key investors include Solstice Capital, Fulcrum Equity Partners, TGap Ventures, Village Ventures, and Valley Ventures.